Status:
WITHDRAWN
Use of Hypochlorous Acid as Prophylaxis in Health Personnel at High Risk of Infection by SARS-CoV 2 (COVID19)
Lead Sponsor:
Hospital Universitario San Ignacio
Collaborating Sponsors:
Pontificia Universidad Javeriana
Conditions:
SARS-CoV Infection
Covid19
Eligibility:
All Genders
18-80 years
Phase:
PHASE2
PHASE3
Brief Summary
The pandemic caused by SARS-CoV-2 is a global emergency present in 6 continents including 66 countries, incurring a shortage of effective and safe therapeutic alternatives that can contribute to reduc...
Detailed Description
Hypochlorous acid (HClO) is a powerful antimicrobial and antiviral used for the control of various infections, repair and washing of surgical wounds, as well as for disinfection of surfaces. In vivo, ...
Eligibility Criteria
Inclusion
- Specialist physicians, resident physicians, medical students, and nursing personnel who work at the San Ignacio University Hospital.
- Subjects of any sex over 18 years of age who work as health care personnel, in care services that care for patients with a suspected or confirmed diagnosis of COVID-19 and who are active during the study recruitment.
- That they have not presented general symptoms such as malaise, fever, cough, dyspnea or muscle pain during the last 7 days.
- Subjects negative to the antigen test for COVID-19.
Exclusion
- Subjects considered as a resolved case of COVID-19 infection, according to guidelines from the Colombian National Institute of Health.
- Health personnel with social distancing due to close contact without personal protective equipment with patients confirmed to be infected or taking any medication as a possible prophylaxis for COVID-19 (example: chloroquine, hydroxychloroquine, azithromycin)
- Health workers who have permits or temporary withdrawal from their hospital work for more than one week during the month of the study.
- Some type of allergy to chlorinated agents or hypersensitivity to HClO
- Known diagnosis of upper airway respiratory disease where COVID-19 such as the common cold, sinusitis, pharyngitis, laryngotracheitis and epiglottitis or lower such as bronchiolitis, pneumonia, and mixed conditions have been ruled out.
- Previous COVID19 infection determined by positive PCR or positive serum antibody titers.
- Any condition that in the principal investigator's discretion renders the subject ineligible to participate in the study.
Key Trial Info
Start Date :
February 15 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 15 2021
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT04684550
Start Date
February 15 2021
End Date
August 15 2021
Last Update
March 3 2023
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.